Immunomodulator (thalidomide/pomalidomide/lenalidomide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immunomodulator (thalidomide/pomalidomide/lenalidomide), covering 2023-02-27 to 2023-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMM [Phase 2]